Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Olivier, Duval"'
Autor:
Bénédicte Bruno, Lucie Capelle, Virginie Denis, Olivier Duval, Sorea Selmouni, Alban Villate, Delphine Cabelguenne, Valérie Coiteux, Tiphaine Lachner-Gaubert, Ibrahim Yakoub-Agha, Nicolas Simon
Publikováno v:
Bulletin du Cancer. 110:S88-S96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d51b9123c169f164f1e18f976f8b08
https://doi.org/10.1016/j.bulcan.2022.02.004
https://doi.org/10.1016/j.bulcan.2022.02.004
Autor:
Milad Baroud, Elise Lepeltier, Yolla El-Makhour, Nolwenn Lautram, Jerome Bejaud, Sylvain Thepot, Olivier Duval
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1317 (2021)
5-Azacitidine, a cytidine analogue used as a hypomethylating agent, is one of the main drugs for the treatment of myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) in the elderly. However, after administration, it exhibits several lim
Externí odkaz:
https://doaj.org/article/b21738572f654089beb9c95d5a35e179
Publikováno v:
Actualités Pharmaceutiques. 61:31-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7561c6f047fc4e59e6dba81348ea84df
https://doi.org/10.1016/j.actpha.2021.12.008
https://doi.org/10.1016/j.actpha.2021.12.008
Autor:
Bénédicte, Bruno, Lucie, Capelle, Virginie, Denis, Olivier, Duval, Sorea, Selmouni, Alban, Villate, Delphine, Cabelguenne, Valérie, Coiteux, Tiphaine, Lachner-Gaubert, Ibrahim, Yakoub-Agha, Nicolas, Simon
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2023, Bulletin du cancer, 110 (2 S), pp.S88-S96. ⟨10.1016/j.bulcan.2022.02.004⟩
Bulletin du Cancer, 2023, Bulletin du cancer, 110 (2 S), pp.S88-S96. ⟨10.1016/j.bulcan.2022.02.004⟩
International audience; Since patients require multiple intravenous drugs, drug incompatibilities and drug interactions are frequent during the acute phase following hematopoietic cell transplantation. The risk of drug-drug interactions is increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a12b20b92b0023b22846b8cb0404f657
https://hal.univ-lille.fr/hal-04159885
https://hal.univ-lille.fr/hal-04159885
Publikováno v:
Nanoscale Advances
Nanoscale Advances, RSC, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
Nanoscale Advances, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
Nanoscale Advances, RSC, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
Nanoscale Advances, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
International audience; Nucleoside and nucleotide analogs are essential tools in our limited arsenal in the fight against cancer. However, these structures face severe drawbacks such as rapid plasma degradation or hydrophilicity, limiting their clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2118cd0e5df5bcfbdf79e618129ed9cd
https://hal.univ-angers.fr/hal-03448613/document
https://hal.univ-angers.fr/hal-03448613/document
Publikováno v:
Pharmaceuticals, Vol 9, Iss 1, p 1 (2015)
The European Conference on Therapeutic Targets and Medicinal Chemistry is a new two-day meeting on drug discovery that is focused on therapeutic targets and the use of tools to explore all fields of drug discovery and drug design such as molecular mo
Externí odkaz:
https://doaj.org/article/ae2ae815e98641cb964268e6d0ce65bb
Autor:
Yannick Abatuci, Olivier Duval, Claire Lugnier, Sébastien Faure, Jean-Jacques Helesbeux, Hélène Justiniano, Samuel Legeay, Kien Trân
Publikováno v:
Current Pharmaceutical Design
Current Pharmaceutical Design, Bentham Science Publishers, 2019, 24 (46), pp.5580-5589. ⟨10.2174/1381612825666190206144913⟩
Current Pharmaceutical Design, Bentham Science Publishers, 2019, 24 (46), pp.5580-5589. ⟨10.2174/1381612825666190206144913⟩
Background: Among polyphenolic compounds suggested to prevent cardiovascular diseases (CVDs) and to explain the “French paradox”, the anthocyanidin delphinidin (Dp) has been reported to support at least partly the vascular beneficial effects of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ce843f13afa6d09b7e8051abf27b05
https://hal.archives-ouvertes.fr/hal-02429620
https://hal.archives-ouvertes.fr/hal-02429620
Autor:
Naima Sait, H. Hammache, Jean-Jacques Helesbeux, Nabila Aliouane, Linda Toukal, Mousa Al-Noaimi, Olivier Duval
Publikováno v:
Journal of Molecular Liquids. 326:115316
The inhibition performance of the newly synthesized Ethylene bis [(2-hydroxy-5,1,3-phenylene) bis methylene] tetraphosphonic acid (ETPA) toward carbon steel in 3% NaCl was investigated at different concentrations using potentiodynamic polarization (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b894c423a4f0ebb5fe9c9ca28e9b9712
https://doi.org/10.1016/j.molliq.2021.115316
https://doi.org/10.1016/j.molliq.2021.115316
Autor:
Faure, Nicolas Clere, Kim Hung Thien To, Samuel Legeay, Samuel Bertrand, Jean Jacques Helesbeux, Olivier Duval, Sébastien
Publikováno v:
Molecules; Volume 22; Issue 4; Pages: 627
Ethoxidine, a benzo[c]phenanthridine derivative, has been identified as a potent inhibitor of topoisomerase I in cancer cell lines. Our group has reported paradoxical properties of ethoxidine in cellular processes leading to angiogenesis on endotheli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::8a1331abef49dc3378abff0b2b572a37
Autor:
Jean-Jacques Hélesbeux, Olivier Duval
Publikováno v:
Pharmaceuticals
The GP2A European Conference is a two-day meeting focused on medicinal chemistry and the use of tools to explore all fields of drug discovery and drug design such as molecular modelling, bioorganic chemistry, MS studies, in vitro in vivo assays, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da2dfb91dde32e8c2b54f3fe8a169af
http://europepmc.org/articles/PMC5374421
http://europepmc.org/articles/PMC5374421